210 related articles for article (PubMed ID: 28544807)
1. Effects of Teriparatide on Joint Erosions in Rheumatoid Arthritis: A Randomized Controlled Trial.
Solomon DH; Kay J; Duryea J; Lu B; Bolster MB; Yood RA; Han R; Ball S; Coleman C; Lo E; Wohlfahrt A; Sury M; Yin M; Yu Z; Zak A; Gravallese EM
Arthritis Rheumatol; 2017 Sep; 69(9):1741-1750. PubMed ID: 28544807
[TBL] [Abstract][Full Text] [Related]
2. Healing of erosions in rheumatoid arthritis remains elusive: results with 24 months of the anabolic agent teriparatide.
Duryea J; Gravallese EM; Wortman JR; Xu C; Lu B; Kay J; Solomon DH
Scand J Rheumatol; 2021 Jan; 50(1):11-14. PubMed ID: 32757870
[No Abstract] [Full Text] [Related]
3. Assessment of 3-month changes in bone microstructure under anti-TNFα therapy in patients with rheumatoid arthritis using high-resolution peripheral quantitative computed tomography (HR-pQCT).
Shimizu T; Choi HJ; Heilmeier U; Tanaka M; Burghardt AJ; Gong J; Chanchek N; Link TM; Graf J; Imboden JB; Li X
Arthritis Res Ther; 2017 Oct; 19(1):222. PubMed ID: 28978352
[TBL] [Abstract][Full Text] [Related]
4. May etanercept and PTH (1-34) association heal erosions in early rheumatoid arthritis? A pilot study.
Migliore A; Massafra U; Bizzi E; Argento G; Diamanti AP; Germano V; Tormenta S; Arduini F; Iannessi F; Granatas M; Laganà B
Eur Rev Med Pharmacol Sci; 2012 Mar; 16(3):363-9. PubMed ID: 22530354
[TBL] [Abstract][Full Text] [Related]
5. Effect of treat-to-target strategies on bone erosion progression in early rheumatoid arthritis: An HR-pQCT study.
Yue J; Griffith JF; Xu J; Xiao F; Shi L; Wang D; Wong PCH; Li EK; Li M; Li TK; Mak WY; Zhu TY; Hung VW; Qin L; Tam LS
Semin Arthritis Rheum; 2018 Dec; 48(3):374-383. PubMed ID: 29858113
[TBL] [Abstract][Full Text] [Related]
6. Erosive progression is minimal, but erosion healing rare, in patients with rheumatoid arthritis treated with adalimumab. A 1 year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measure.
Møller Døhn U; Boonen A; Hetland ML; Hansen MS; Knudsen LS; Hansen A; Madsen OR; Hasselquist M; Møller JM; Østergaard M
Ann Rheum Dis; 2009 Oct; 68(10):1585-90. PubMed ID: 19019887
[TBL] [Abstract][Full Text] [Related]
7. Impact of switching oral bisphosphonates to denosumab or daily teriparatide on the progression of radiographic joint destruction in patients with biologic-naïve rheumatoid arthritis.
Ebina K; Hirao M; Hashimoto J; Matsuoka H; Iwahashi T; Chijimatsu R; Etani Y; Okamura G; Miyama A; Yoshikawa H
Osteoporos Int; 2018 Jul; 29(7):1627-1636. PubMed ID: 29574517
[TBL] [Abstract][Full Text] [Related]
8. Repair of bone erosions in rheumatoid arthritis treated with tumour necrosis factor inhibitors is based on bone apposition at the base of the erosion.
Finzel S; Rech J; Schmidt S; Engelke K; Englbrecht M; Stach C; Schett G
Ann Rheum Dis; 2011 Sep; 70(9):1587-93. PubMed ID: 21622765
[TBL] [Abstract][Full Text] [Related]
9. Micro-structural bone changes in early rheumatoid arthritis persist over 1-year despite use of disease modifying anti-rheumatic drug therapy.
Feehan LM; Li LL; McKay HA
BMC Musculoskelet Disord; 2017 Dec; 18(1):521. PubMed ID: 29228959
[TBL] [Abstract][Full Text] [Related]
10. No overall progression and occasional repair of erosions despite persistent inflammation in adalimumab-treated rheumatoid arthritis patients: results from a longitudinal comparative MRI, ultrasonography, CT and radiography study.
Døhn UM; Ejbjerg B; Boonen A; Hetland ML; Hansen MS; Knudsen LS; Hansen A; Madsen OR; Hasselquist M; Møller JM; Ostergaard M
Ann Rheum Dis; 2011 Feb; 70(2):252-8. PubMed ID: 20980282
[TBL] [Abstract][Full Text] [Related]
11. Repair of Bone Erosion in Rheumatoid Arthritis by Denosumab: A High-Resolution Peripheral Quantitative Computed Tomography Study.
Yue J; Griffith JF; Xiao F; Shi L; Wang D; Shen J; Wong P; Li EK; Li M; Li TK; Zhu TY; Hung VW; Qin L; Tam LS
Arthritis Care Res (Hoboken); 2017 Aug; 69(8):1156-1163. PubMed ID: 27768831
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of the inhibitory effect on bone erosion progression with denosumab treatment and conventional treatment in rheumatoid arthritis patients: study protocol for an open-label randomized controlled trial by HR-pQCT.
Iwamoto N; Sato S; Sumiyoshi R; Chiba K; Miyamoto N; Arinaga K; Kobayashi M; Yamamoto H; Osaki M; Kawakami A
Trials; 2019 Aug; 20(1):494. PubMed ID: 31409388
[TBL] [Abstract][Full Text] [Related]
13. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA).
Hetland ML; Ejbjerg B; Hørslev-Petersen K; Jacobsen S; Vestergaard A; Jurik AG; Stengaard-Pedersen K; Junker P; Lottenburger T; Hansen I; Andersen LS; Tarp U; Skjødt H; Pedersen JK; Majgaard O; Svendsen AJ; Ellingsen T; Lindegaard H; Christensen AF; Vallø J; Torfing T; Narvestad E; Thomsen HS; Ostergaard M;
Ann Rheum Dis; 2009 Mar; 68(3):384-90. PubMed ID: 18388160
[TBL] [Abstract][Full Text] [Related]
14. Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial.
Jensen TW; Hansen MS; Hørslev-Petersen K; Hyldstrup L; Abrahamsen B; Langdahl B; Zerahn B; Pødenphant J; Stengaard-Petersen K; Junker P; Østergaard M; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen AJ; Tarp U; Lindegaard H; Jurik AG; Vestergaard A; Hetland ML;
Ann Rheum Dis; 2014 Jun; 73(6):1123-9. PubMed ID: 23661492
[TBL] [Abstract][Full Text] [Related]
15. Correlation of structural abnormalities of the wrist and metacarpophalangeal joints evaluated by high-resolution peripheral quantitative computed tomography, 3 Tesla magnetic resonance imaging and conventional radiographs in rheumatoid arthritis.
Lee CH; Srikhum W; Burghardt AJ; Virayavanich W; Imboden JB; Link TM; Li X
Int J Rheum Dis; 2015 Jul; 18(6):628-39. PubMed ID: 25293500
[TBL] [Abstract][Full Text] [Related]
16. Relationship between early bone mineral density changes and long-term function and radiographic progression in rheumatoid arthritis.
Bejarano V; Hensor E; Green M; Haugeberg G; Brown AK; Buch MH; Emery P; Conaghan PG
Arthritis Care Res (Hoboken); 2012 Jan; 64(1):66-70. PubMed ID: 21770041
[TBL] [Abstract][Full Text] [Related]
17. Periarticular bone gain at proximal interphalangeal joints and changes in bone turnover markers in response to tumor necrosis factor inhibitors in rheumatoid and psoriatic arthritis.
Szentpetery A; McKenna MJ; Murray BF; Ng CT; Brady JJ; Morrin M; Radovits B; Veale DJ; Fitzgerald O
J Rheumatol; 2013 May; 40(5):653-62. PubMed ID: 23457381
[TBL] [Abstract][Full Text] [Related]
18. Bone erosion in the 2nd metacarpophalangeal head: association with its bone mineral density by HR-pQCT in rheumatoid arthritis patients.
Figueiredo CP; Perez MO; Sales LP; Medeiros AC; Caparbo VF; Pereira RMR
BMC Musculoskelet Disord; 2021 Jan; 22(1):109. PubMed ID: 33494725
[TBL] [Abstract][Full Text] [Related]
19. Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.
Leder BZ; Tsai JN; Uihlein AV; Wallace PM; Lee H; Neer RM; Burnett-Bowie SA
Lancet; 2015 Sep; 386(9999):1147-55. PubMed ID: 26144908
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of denosumab with regard to bone destruction in prognostic subgroups of Japanese rheumatoid arthritis patients from the phase II DRIVE study.
Ishiguro N; Tanaka Y; Yamanaka H; Yoneda T; Ohira T; Okubo N; Genant HK; van der Heijde D; Takeuchi T
Rheumatology (Oxford); 2019 Jun; 58(6):997-1005. PubMed ID: 30602032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]